期刊文献+

^(18)FDG-PET/CT及CeMSCT联合诊断原发性肝细胞癌研究 被引量:3

Application of ^(18)FDG-PET/CT and CeMSCT in primary hepatocellular carcinoma
下载PDF
导出
摘要 目的探讨联合应用PET/CT及MSCT在肝脏原发性肝细胞癌中的诊断价值。方法收集明确诊断的原发性肝癌38例,18FDG-PET及CeMSCT检查后进行回顾性总结分析,按病灶大小进行分组,并按浓聚程度不同进行分级(1-4级)。结果CeM-SCT对肝癌诊断敏感性为68.4%,PET/CT对肝癌诊断敏感性为52.6%,联合诊断肝癌的敏感性为73.7%。病灶大小之间诊断效能有差异,肝癌的浓聚程度分级1-2级占55.3%,3-4级占44.7%。结论联合应用PET/CT及CeMSCT对原发性肝细胞癌可以提高大于3 cm肝癌诊断的敏感性,并对临床分期、指导治疗和预后的判断具有重要的价值,对于小于3 cm肝癌联合诊断仍需进一步探讨。 Objective To investigate the diagnostic value of PET/CT and CeCT in primary hepatocellular carcinoma. Methods thirty-eight cases with primary hepatoeellular carcinoma which had been clearly diagnosed by pathology, have been examined by PET/CT and CeMSCT, and then we analyzed retrospectively these data by PET and CT specialists. We divide two groups according to the size of focal and classified four grade according to different dense degree. Results The sensitivity of CeMSCT is 68.4% in primary hepatoeellular carcinoma diagnosis and PET/CT was 52.6% and PET plus CeMSCT was 73.7%. There are significance different in two groups in the diagnosis power. According to different grade eriterionl, 1 -2grade was 55.3% and 3 -4 grade was 44.7%. Conclusion Combined PET/CT and CeMSCT may improve the sensitivity in primary hepatoeellular carcinoma of 〉 3cm, and at same time, it is very important for patients to renew elinieal stage and direet treatment and predietion prognostie, but there are no important value in less 3cm focal of primary hepatoeellular carcinoma.
出处 《胃肠病学和肝病学杂志》 CAS 2007年第2期162-164,共3页 Chinese Journal of Gastroenterology and Hepatology
关键词 PET MSCT 原发性肝细胞癌 FDG PET MSCT Primary Hepatocellular carcinoma FDG
  • 相关文献

参考文献11

  • 1Wudel LJ Jr, Delbeke D, Morris D, et al. The role of [ 18F ] fluorodeoxyglucose positron emission tomography imaging in the evaluation of hepatocellular carcinoma[J]. Am Surg, 2003, 69(2):117-24.
  • 2Shiomi S, Nishiguehi S, lshizu H, et al. Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose for predicting outcome in patients with hepatocellular carcinoma [ J ]. Am J Gastroenterol,2001,96(6) : 1877-1880.
  • 3Ho CL, Yu SC, Yeung DW. 11C -acetate PET imaging in hepatocellular carcinoma and other liver masses[ J]. J Nucl Med,2003,44(2 ): 213-21.
  • 4Khan MA, Combs CS, Brunt EM,et al. Positron emission tomography scanning in the evaluation of hepatocellular carcinoma [ J ]. J Hepatol, 2000,32 ( 5 ) :792-797.
  • 5吴恩惠,主编.医学影像学[M].第5版.人民卫生出版社,2003.237.
  • 6Trojan J, Schroeder O, Raedle J,et al. Fluorine-18 FDG positron emissiontomography for imaging of hepatocellular carcinoma[ J]. Am J Gastroenterol, 1999,94( 11 ) :3314-3319.
  • 7Son HB, Han C J, Kim BI, et al. Evaluation of various hepatic lesions with positron emission tomography [ J ]. Taehan Kan Hakhoe Chi, 2002,8 (4) :472-480.
  • 8Oehr P, Biersack H J. Coleman E. PET and PET-CT in Oncology[ M ]. New York : Springer-Verlag Berlin Heidelberg,2004. 205-210.
  • 9杜忆兵,吴泽新,文明,王志兵,徐玉卡,马莲花,龙海彪.螺旋CT双期扫描对伴肝硬化的小肝癌的诊断价值[J].中华放射学杂志,1999,33(4):255-257. 被引量:25
  • 10Anderson GS, Brinkmann F, Soulen MC, et al. FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation[ J]. Clin Nucl Med ,2003,28(3 ) :192-197.

二级参考文献2

共引文献25

同被引文献43

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部